AVADEL PHARMACEUTICALS PLC (AVDL) has 68 open-market insider trades by 18 insiders since 2017. The most active filer is Eric J. Ende, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Andrew M. Weiss | — | — | 1 | $233.4M | 2026-02-13 |
| Craig R. Stapleton | Dir | — | 4 | $4.1M | 2018-08-01 |
| Craig R. Stapleton | Dir | — | 5 | $3.6M | 2017-12-15 |
| Mark Anthony McCamish | Dir | — | 2 | $2.8M | 2026-02-12 |
| Broadfin Healthcare Master Fund Ltd | 10% Owner | — | 1 | $2.8M | 2019-01-31 |
| Deerfield Management Company, L.P. (series C) via Keith Crandell | 10% Owner | — | 1 | $1.4M | 2018-06-25 |
| Eric J. Ende | Dir | — | 10 | $1.1M | 2026-02-12 |
| Geoffrey Michael Glass | Dir | — | 7 | $1.0M | 2026-02-12 |
| Gregory J. Divis | CEO | — | 4 | $634K | 2026-02-12 |
| Guillaume Cerutti | Dir | — | 1 | $556K | 2017-06-15 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Andrew M. Weiss | — | Sell | $233.4M | 2026-02-13 |
| Linda Palczuk | Director | Buy | $40K | 2025-01-21 |
| Peter J. Thornton | Director | Buy | $81K | 2025-01-13 |
| Eric J. Ende | Director | Buy | $235K | 2025-01-13 |
| Thomas S. McHugh | CFO | Buy | $24K | 2024-12-13 |
| Thomas S. McHugh | CFO | Buy | $52K | 2024-12-11 |
Companies that share insiders with AVDL, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Geoffrey Michael Glass | Director | Buy | $399K | 2024-12-10 |
| Gregory J. Divis | CEO | Buy | $196K | 2024-12-06 |
| Linda Palczuk | Director | Buy | $31K | 2024-12-06 |
| Thomas S. McHugh | CFO | Buy | $29K | 2024-01-16 |
| Mark Anthony McCamish | Director | Sell | $1.1M | 2023-12-28 |
| Thomas S. McHugh | CFO | Buy | $29K | 2023-08-14 |
| Mark Anthony McCamish | Director | Sell | $865K | 2023-08-11 |
| Geoffrey Michael Glass | Director | Buy | $188K | 2023-08-10 |
| Gregory J. Divis | CEO | Buy | $132K | 2023-08-10 |